- ISIN
- US24661P8077
- CUSIP
- 24661P807
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- May 29, 2018
Highlights
- Market Cap
- $414.60M
- Enterprise Value
- $374.29M
- EPS (TTM)
- $0.01
- PE Ratio
- 783.68
- Total Revenue (TTM)
- $65.45M
- Gross Profit (TTM)
- $77.75M
- EBITDA (TTM)
- $222.00K
- Year Range
- $8.12 - $14.18
- Target Price
- $23.00
- ROA (TTM)
- 0.45%
- ROE (TTM)
- 0.50%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
DCTH Performance Chart
Delcath Systems, Inc. (DCTH) is up 14.0% since the beginning of the year. At $12 per share, DCTH is trading 18.8% below its 52-week high of $14. Investors who bought $1,000 worth of DCTH shares 5 years ago would now be looking at an investment worth $1,100.
Loading charts...
Returns By Period
Delcath Systems, Inc. (DCTH) has returned 13.96% so far this year and -16.90% over the past 12 months.
Delcath Systems, Inc.
- 1D
- -1.54%
- 1M
- 4.45%
- YTD
- 13.96%
- 6M
- 14.30%
- 1Y
- -16.90%
- 3Y*
- 27.37%
- 5Y*
- 1.93%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
DCTH Monthly Returns History
Based on dividend-adjusted daily data since May 29, 2018, DCTH's average daily return is -0.04%, while the average monthly return is -2.50%.
Historically, 41% of months were positive and 59% were negative. The best month was Aug 2019 with a return of +64.4%, while the worst month was Oct 2018 at -70.9%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.
On a daily basis, DCTH closed higher 44% of trading days. The best single day was Apr 16, 2019 with a return of +126.3%, while the worst single day was Nov 8, 2019 at -42.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.88% | -10.19% | 4.27% | 11.85% | 3.85% | 6.77% | 13.96% | ||||||
| 2025 | 29.57% | -9.17% | -10.16% | -5.42% | 34.63% | -16.10% | -20.96% | 2.51% | -2.45% | -8.56% | -1.32% | 4.12% | -16.11% |
| 2024 | 15.14% | -12.94% | 14.39% | 9.01% | 35.58% | 18.72% | 2.99% | 27.61% | -17.91% | 20.60% | 9.09% | 1.35% | 189.42% |
| 2023 | 3.61% | 32.98% | 15.93% | -0.35% | 38.92% | -26.76% | -24.87% | 4.79% | -11.76% | -22.22% | -12.70% | 51.27% | 15.56% |
| 2022 | -10.97% | -6.23% | -1.08% | -5.63% | -23.68% | -13.45% | 4.51% | 1.56% | -24.44% | -10.00% | -1.04% | 26.32% | -53.55% |
| 2021 | -9.88% | 11.52% | -31.04% | -10.55% | -3.69% | 17.85% | -19.11% | -1.96% | 4.40% | 6.42% | -10.62% | -21.95% | -56.75% |
Benchmark Metrics
Delcath Systems, Inc. has an annualized alpha of -17.86%, beta of 0.63, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since May 29, 2018.
- This stock participated in 145.47% of S&P 500 Index downside but only -69.24% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.63 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -17.86%
- Beta
- 0.63
- R²
- 0.01
- Upside Capture
- -69.24%
- Downside Capture
- 145.47%
Return for Risk
Risk / Return Rank
DCTH ranks 28 for risk / return — below 28% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Delcath Systems, Inc. (DCTH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DCTH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.37 | ||
| Sortino ratioReturn per unit of downside risk | -2.93 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.37 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.41 | 2.78 | -3.19 |
| Martin ratioReturn relative to average drawdown | -0.64 | 12.44 | -13.08 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Delcath Systems, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Delcath Systems, Inc. was 99.96%, occurring on Nov 14, 2023. The portfolio has not yet recovered.
The current Delcath Systems, Inc. drawdown is 99.81%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -99.96%Nov 2023 | 5y 1mo | — | 7y 9moSep 2018 - now |
2018 bear market2018 | -49.43%Aug 2018 | 2mo 22d | 22d | 3mo 14dJun 2018 - Sep 2018 |
2018 pullback2018 | -0.30%May 2018 | 0s | 1d | 1dMay 2018 - May 2018 |
Drawdown Indicators
| DCTH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | -56.78% | -43.18% |
Max Drawdown (1Y)Largest decline over 1 year | -41.71% | -9.10% | -32.61% |
Max Drawdown (3Y)Largest decline over 3 years | -62.87% | -18.90% | -43.97% |
Max Drawdown (5Y)Largest decline over 5 years | -82.21% | -25.43% | -56.78% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.81% | -1.80% | -98.01% |
Average DrawdownAverage peak-to-trough decline | -96.43% | -10.71% | -85.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.33% | 2.03% | +24.30% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Delcath Systems, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Delcath Systems, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DCTH, comparing it with other companies in the Medical Devices industry. Currently, DCTH has a P/E ratio of 783.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DCTH relative to other companies in the Medical Devices industry. Currently, DCTH has a P/S ratio of 6.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DCTH in comparison with other companies in the Medical Devices industry. Currently, DCTH has a P/B value of 3.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with DCTH
Add Delcath Systems, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with DCTH